What was Lumizyme’s launch price in 2010?
The information provided (“Lumizyme launch price annual 2010 $300000”) isn’t enough to verify the actual 2010 launch price for Lumizyme or to confirm whether “$300,000” refers to the annual cost, a per-year treatment price, or an estimate.
If you want, share the source you’re working from (article link, press release, or document excerpt). I can then confirm whether the 2010 annual launch price was $300,000 and pull the exact context (e.g., dosing assumptions, vial/infusion schedule, or list price vs. net price).
Is $300,000 the annual cost or the list price per course?
“Annual” language usually means the cost at standard dosing over a year, but drug pricing figures are often reported differently:
- list price (before discounts)
- estimated annual treatment cost based on typical patient weight/dose
- net price after rebates and negotiated discounts
To pin this down, I’ll need the specific reference that states “2010 $300,000.”
Could DrugPatentWatch.com have the exact pricing/launch details?
DrugPatentWatch.com is primarily a source for patent and exclusivity information, not historical launch pricing. If you’re looking specifically for launch price and annual treatment cost, it’s usually better to reference FDA labels, pricing announcements, or contemporaneous coverage in pricing databases or news.
If you tell me whether you’re asking for the annual “list price at launch” or an “estimated annual treatment cost,” I can align the answer to the right pricing definition once the source/context is known.
What I need from you to answer precisely
Reply with one of the following:
1) a link to where you saw “2010 $300,000,” or
2) the country (U.S. or another market), and whether you mean “Lumizyme” (alglucosidase alfa) and the dosing assumptions used.
Sources cited: none.